Guillaume Macary, Jérome Rossert, Patrick Bruneval, Chantal Mandet, Marie-France Bélair, Pascal Houillier, Jean-Paul Duong Van Huyen
Index: Virchows Arch. 456(3) , 325-37, (2010)
Full Text: HTML
The present work identifies a new mouse model of inductible acute glomerular injury leading to focal segmental glomerulonephritis. We take advantage of the suicide gene/prodrug nitroreductase/CB1954 combination, in which nitroreductase converts CB1954, a monofunctional alkylating agent, into its toxic form. We generate two lines of transgenic mice in which the nitroreductase gene was placed under the control of the podocyte-specific gene podocin. The functional analysis of transgenic mice lines showed that CB1954 treatment induced a severe but transitory proteinuria. Sequential histopathological analysis was performed on serial kidney biopsies. Injured glomeruli showed acute lesions with early podocyte vacuolization and detachment, podocyte apoptosis, and cellular proliferation leading to a marked hypercellularity of the urinary space that was associated with collapsing of the glomerular tuft. After 1 month, progressive scarring lead to focal segmental glomerulosclerosis with fibrous capsular adhesion, hyalinosis, and podocytosis associated with interstitial fibrosis. The phenotype of podocytes was changed exhibiting dedifferentiation characterized by the loss of podocyte specific proteins/transcription factor and the expression of injury markers. Bowman's capsule cells were also involved in the cellular changes in a manner suggesting epithelial to mesenchymal transition. This model of podocyte injury in transgenic mice provides new insights into the cellular mechanisms of podocytopathies and their progression to scarring.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
CB 1954
CAS:21919-05-1 |
C9H8N4O5 |
An unusually cold active nitroreductase for prodrug activati...
2012-06-01 [Bioorg. Med. Chem. 20(11) , 3540-50, (2012)] |
uvrB gene deletion enhances SOS chromotest sensitivity for n...
2010-10-01 [J. Biotechnol. 150(1) , 190-4, (2010)] |
CB 1954: from the Walker tumor to NQO2 and VDEPT.
2003-01-01 [Curr. Pharm. Des. 9(26) , 2091-104, (2003)] |
Colloidal gold modified with a genetically engineered nitror...
2011-12-06 [Langmuir 27(23) , 14300-7, (2011)] |
Antivector and tumor immune responses following adenovirus-d...
2009-11-01 [Hum. Gene Ther. 20(11) , 1249-58, (2009)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved